FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Diane Provencher

Research Profile

Disorders

Devices

Oligonucleotide Array Sequence Analysis

Anatomy

Procedures

Chemicals & Drugs

Geographic Areas

Canada

Physiology

Phenomena

Founder Effect

Co-author Network

Publications

TOP 3
Marc Tischkowitz; William D Foulkes; Nancy Hamel; Anne-Marie Mes-Masson; Carly Pouchet; Diane Provencher; Nelly Sabbaghian; Patricia N Tonin
Contribution of the PALB2 c.2323C>T [p.Q775X] founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent.
Simon Grandjean Lapierre; Marie-Hélène Mayrand; Bertrand Michon; Stéphan Ouellet; Patrick Petignat; Diane Provencher; Philippe Sauthier; Pierre Drouin; Simon Dufresne; Marie-Josée Dupuis; Alex Ferenczy; Eduardo L Franco; Philippe Gauthier; Rachid Hadjeres; François Coutlée
Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix.
P Wojnarowicz; M de Ladurantaye; K Gambaro; Anne-Marie Mes-Masson; Diane Provencher; M C J Quinn; Patricia N Tonin
Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicity.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Diane Provencher (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marc Tischkowitz; William D Foulkes; Nancy Hamel; Anne-Marie Mes-Masson; Carly Pouchet; Diane Provencher; Nelly Sabbaghian; Patricia N Tonin
Contribution of the PALB2 c.2323C>T [p.Q775X] founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent.
BMC medical genetics 2013;14():5.
2012: Simon Grandjean Lapierre; Marie-Hélène Mayrand; Bertrand Michon; Stéphan Ouellet; Patrick Petignat; Diane Provencher; Philippe Sauthier; Pierre Drouin; Simon Dufresne; Marie-Josée Dupuis; Alex Ferenczy; Eduardo L Franco; Philippe Gauthier; Rachid Hadjeres; François Coutlée
Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix.
Journal of clinical microbiology 2012;50(4):1240-4.
2012: P Wojnarowicz; M de Ladurantaye; K Gambaro; Anne-Marie Mes-Masson; Diane Provencher; M C J Quinn; Patricia N Tonin
Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicity.
Oncogenesis 2012;1():e27.
2012: Paulina M Wojnarowicz; Suzanna L Arcand; Ashley H Birch; M de Ladurantaye; Karen Gambaro; Celia M T Greenwood; Jason Madore; Anne-Marie Mes-Masson; Kathleen K Oros; Diane Provencher; Michael C J Quinn; Kurosh Rahimi; Patricia N Tonin
The genomic landscape of TP53 and p53 annotated high grade ovarian serous carcinomas from a defined founder population associated with patient outcome.
PloS one 2012;7(9):e45484.
2012: Isabelle J Létourneau; Suzanna L Arcand; Katia Y Caceres; Louis Cyr; M de Ladurantaye; Nathalie Delvoye; Liliane Meunier; Lise Portelance; Diane Provencher; Michael C J Quinn; Zhen Shen; Patricia N Tonin; Lu-Lin Wang; Anne-Marie Mes-Masson
Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer.
BMC cancer 2012;12():379.
2011: Philippe Gannon; Sanae Medelci; Cecile Le Page; Martin Beaulieu; Diane Provencher; Anne-Marie Mes-Masson; Manuela M Santos
Impact of hemochromatosis gene (HFE) mutations on epithelial ovarian cancer risk and prognosis.
International journal of cancer. Journal international du cancer 2011;128(10):2326-34.
2011: Simon Dufresne; Philippe Sauthier; Marie-Hélène Mayrand; Patrick Petignat; Diane Provencher; Pierre Drouin; Philippe Gauthier; Marie-Josée Dupuis; Bertrand Michon; Stéphan Ouellet; Rachid Hadjeres; Alex Ferenczy; Eduardo L Franco; François Coutlée
Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with Amplicor HPV and Hybrid Capture 2 assays for detection of high-grade lesions of the uterine cervix.
Journal of clinical microbiology 2011;49(1):48-53.
2010: Melissa Henry; S Robin Cohen; Virginia Lee; Philippe Sauthier; Diane Provencher; Pierre Drouin; Philippe Gauthier; Walter H Gotlieb; Susie Lau; Nancy Drummond; Lucy Gilbert; Gerald Stanimir; Jeremy Sturgeon; Martin Chasen; Julie Mitchell; Lina Nuoxin Huang; Mira-Klode Ferland; Nancy Mayo
The Meaning-Making intervention (MMi) appears to increase meaning in life in advanced ovarian cancer: a randomized controlled pilot study.
Psycho-oncology 2010;19(12):1340-7.
2010: Luca Cavallone; Suzanna L Arcand; Christine M Maugard; Serge Nolet; Louis A Gaboury; Anne-Marie Mes-Masson; Parviz Ghadirian; Diane Provencher; Patricia N Tonin
Comprehensive BRCA1 and BRCA2 mutation analyses and review of French Canadian families with at least three cases of breast cancer.
Familial cancer 2010;9(4):507-17.
2010: Magdalena Zietarska; Jason Madore; Jean-Simon Diallo; Nathalie Delvoye; Fred Saad; Diane Provencher; Anne-Marie Mes-Masson
A novel method of cell embedding for tissue microarrays.
Histopathology 2010;57(2):323-9.
2010: Isabelle Trop; L Lalonde; Marie-Hélène Mayrand; J David; N Larouche; Diane Provencher
Multimodality breast cancer screening in women with a familial or genetic predisposition.
Current oncology (Toronto, Ont.) 2010;17(3):28-36.
2010: Jason Madore; Fengge Ren; Ali Filali-Mouhim; Lilia Sanchez; Martin Köbel; Patricia N Tonin; David Huntsman; Diane Provencher; Anne-Marie Mes-Masson
Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma.
The Journal of pathology 2010;220(3):392-400.
2010: Véronique Barrès; Véronique Ouellet; Julie Lafontaine; Patricia N Tonin; Diane Provencher; Anne-Marie Mes-Masson
An essential role for Ran GTPase in epithelial ovarian cancer cell survival.
Molecular cancer 2010;9():272.
2010: Liliane Meunier; Marie-Line Puiffe; Cécile Le Page; Abdelali Filali-Mouhim; Mario Chevrette; Patricia N Tonin; Diane Provencher; Anne-Marie Mes-Masson
Effect of ovarian cancer ascites on cell migration and gene expression in an epithelial ovarian cancer in vitro model.
Translational oncology 2010;3(4):230-8.
2010: Karine Normandin; Benjamin Péant; Cecile Le Page; M de Ladurantaye; Véronique Ouellet; Patricia N Tonin; Diane Provencher; Anne-Marie Mes-Masson
Protease inhibitor SERPINA1 expression in epithelial ovarian cancer.
Clinical & experimental metastasis 2010;27(1):55-69.
2009: Neal A L Cody; Zhen Shen; Jean-Sebastien Ripeau; Diane Provencher; Anne-Marie Mes-Masson; Mario Chevrette; Patricia N Tonin
Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer.
Molecular carcinogenesis 2009;48(12):1077-92.
2009: Michael C J Quinn; Abdelali Filali-Mouhim; Diane Provencher; Anne-Marie Mes-Masson; Patricia N Tonin
Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer.
Molecular carcinogenesis 2009;48(7):648-61.
2009: Emily N Manderson; Ashley H Birch; Zhen Shen; Anne-Marie Mes-Masson; Diane Provencher; Patricia N Tonin
Molecular genetic analysis of a cell adhesion molecule with homology to L1CAM, contactin 6, and contactin 4 candidate chromosome 3p26pter tumor suppressor genes in ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(4):513-25.
2009: Michelle Proulx; Marie-Dominique Beaulieu; Christine Loignon; Marie-Hélène Mayrand; Christine Maugard; Nathalie Bellavance; Diane Provencher
Experiences and decisions that motivate women at increased risk of breast cancer to participate in an experimental screening program.
Journal of genetic counseling 2009;18(2):160-72.
2009: Michael C J Quinn; Daniel J Wilson; Fiona Young; Adam A Dempsey; Suzanna L Arcand; Ashley H Birch; Paulina M Wojnarowicz; Diane Provencher; Anne-Marie Mes-Masson; David Englert; Patricia N Tonin
The chemiluminescence based Ziplex automated workstation focus array reproduces ovarian cancer Affymetrix GeneChip expression profiles.
Journal of translational medicine 2009;7():55.
2009: Cecile Le Page; Marie-Line Puiffe; Liliane Meunier; Magdalena Zietarska; M de Ladurantaye; Patricia N Tonin; Diane Provencher; Anne-Marie Mes-Masson
BMP-2 signaling in ovarian cancer and its association with poor prognosis.
Journal of ovarian research 2009;2():4.
2009: Valérie Hétu; Patrick Petignat; Yucan Wu; Pierre Drouin; Philippe Sauthier; Diane Provencher; Philippe Gauthier
Positive adnexal or uterine serosal involvement in stage IIIC endometrial cancer is an adverse factor for recurrence.
Gynecologic and obstetric investigation 2009;67(3):173-7.
2008: P M Wojnarowicz; A Breznan; Suzanna L Arcand; Abdelali Filali-Mouhim; Diane Provencher; Anne-Marie Mes-Masson; Patricia N Tonin
Construction of a chromosome 17 transcriptome in serous ovarian cancer identifies differentially expressed genes.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18(5):963-75.
2008: Steven Ades; Anita Koushik; Eliane Duarte; Nabil Mansour; Jocelyne Arseneau; Diane Provencher; Lucy Gilbert; Walter Gotlieb; Alex Ferenczy; François Coutlée; Michel Roger; Eduardo L Franco
Selected class I and class II HLA alleles and haplotypes and risk of high-grade cervical intraepithelial neoplasia.
International journal of cancer. Journal international du cancer 2008;122(12):2820-6.
2008: Cecile Le Page; Véronique Ouellet; Michael C J Quinn; Patricia N Tonin; Diane Provencher; Anne-Marie Mes-Masson
BTF4/BTNA3.2 and GCS as candidate mRNA prognostic markers in epithelial ovarian cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(4):913-20.
2008: Suzanna L Arcand; Christine M Maugard; Parviz Ghadirian; André Robidoux; Chantal Perret; Phil Zhang; Eve Fafard; Anne-Marie Mes-Masson; William D Foulkes; Diane Provencher; Steven A Narod; Patricia N Tonin
Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families.
Breast cancer research and treatment 2008;108(3):399-408.
2008: Véronique Ouellet; Tak Hay Ling; Karine Normandin; Jason Madore; Christian Lussier; Véronique Barrès; Dimcho Bachvarov; Claudine Rancourt; Patricia N Tonin; Diane Provencher; Anne-Marie Mes-Masson
Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors.
BMC cancer 2008;8():346.
2008: Neal Al Cody; Magdalena Zietarska; Abdelali Filali-Mouhim; Diane Provencher; Anne-Marie Mes-Masson; Patricia N Tonin
Influence of monolayer, spheroid, and tumor growth conditions on chromosome 3 gene expression in tumorigenic epithelial ovarian cancer cell lines.
BMC medical genomics 2008;1():34.
2008: Véronique Ouellet; Magdalena Zietarska; Lise Portelance; Julie Lafontaine; Jason Madore; Marie-Line Puiffe; Suzanna L Arcand; Zhen Shen; Josée Hébert; Patricia N Tonin; Diane Provencher; Anne-Marie Mes-Masson
Characterization of three new serous epithelial ovarian cancer cell lines.
BMC cancer 2008;8():152.
2008: Luca Cavallone; Suzanna L Arcand; Christine Maugard; Parviz Ghadirian; Anne-Marie Mes-Masson; Diane Provencher; Patricia N Tonin
Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent.
BMC cancer 2008;8():96.
2008: Ashley H Birch; Michael C J Quinn; Abdelali Filali-Mouhim; Diane Provencher; Anne-Marie Mes-Masson; Patricia N Tonin
Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes.
Molecular carcinogenesis 2008;47(1):56-65.
2007: Marie-Line Puiffe; Cecile Le Page; Abdelali Filali-Mouhim; Magdalena Zietarska; Véronique Ouellet; Patricia N Tonin; Mario Chevrette; Diane Provencher; Anne-Marie Mes-Masson
Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer.
Neoplasia (New York, N.Y.) 2007;9(10):820-9.
2007: Magdalena Zietarska; Christine M Maugard; Abdelali Filali-Mouhim; Mona Alam Fahmy; Patricia N Tonin; Diane Provencher; Anne-Marie Mes-Masson
Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC).
Molecular carcinogenesis 2007;46(10):872-85.
2007: Véronique Ouellet; Cecile Le Page; Jason Madore; Marie-Claude Guyot; Véronique Barrès; Christian Lussier; Patricia N Tonin; Diane Provencher; Anne-Marie Mes-Masson
An apoptotic molecular network identified by microarray: on the TRAIL to new insights in epithelial ovarian cancer.
Cancer 2007;110(2):297-308.
2007: Michael Fung Kee Fung; Diane Provencher; B Rosen; P Hoskins; L Rambout; thomas oliver; Walter H Gotlieb; Allan Covens
Intraperitoneal chemotherapy for patients with advanced ovarian cancer: a review of the evidence and standards for the delivery of care.
Gynecologic oncology 2007;105(3):747-56.
2007: Patrick Petignat; Andreas du Bois; Ilan Bruchim; Daniel Fink; Diane Provencher
Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?
Critical reviews in oncology/hematology 2007;62(2):137-47.
2007: Andrea Schaffer; Anita Koushik; Helen Trottier; Eliane Duarte; Nabil Mansour; Jocelyne Arseneau; Diane Provencher; Lucy Gilbert; Walter H Gotlieb; Alex Ferenczy; François Coutlée; Michael N Pollak; Eduardo L Franco
Insulin-like growth factor-I and risk of high-grade cervical intraepithelial neoplasia.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(4):716-22.
2007: C Williams; Patrick Petignat; Abdulaziz Alobaid; Diane Provencher; Philippe Gauthier
Chylous ascites after pelvic lymph node dissection for gynecologic cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2007;33(3):399-400.
2007: N A L Cody; Véronique Ouellet; Emily N Manderson; M C J Quinn; Abdelali Filali-Mouhim; Patricia Andrea Tellis; Magdalena Zietarska; Diane Provencher; Anne-Marie Mes-Masson; Mario Chevrette; Patricia N Tonin
Transfer of chromosome 3 fragments suppresses tumorigenicity of an ovarian cancer cell line monoallelic for chromosome 3p.
Oncogene 2007;26(4):618-32.
2007: Kelly A Metcalfe; Parviz Ghadirian; Barry P Rosen; William Foulkes; Charmaine Kim-Sing; Andrea Eisen; Peter Ainsworth; Doug Horsman; Christine Maugard; Diane Provencher; André Robideaux; Dawna Gilchrist; Albert Chudley; Edmond G Lemire; Susan Armel; Amy Finch; Ping Sun; Steven A Narod
Variation in rates of uptake of preventive options by Canadian women carrying the BRCA1 or BRCA2 genetic mutation.
Open medicine : a peer-reviewed, independent, open-access journal 2007;1(2):e92-8.
2007: Patricia N Tonin; Christine M Maugard; Chantal Perret; Anne-Marie Mes-Masson; Diane Provencher
A review of histopathological subtypes of ovarian cancer in BRCA-related French Canadian cancer families.
Familial cancer 2007;6(4):491-7.
2007: Marie-Hélène Benoît; Thomas J Hudson; Georges Maire; Jeremy A Squire; Suzanna L Arcand; Diane Provencher; Anne-Marie Mes-Masson; Patricia N Tonin
Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines.
International journal of oncology 2007;30(1):5-17.
2006: Véronique Ouellet; Cecile Le Page; Marie-Claude Guyot; Christian Lussier; Patricia N Tonin; Diane Provencher; Anne-Marie Mes-Masson
SET complex in serous epithelial ovarian cancer.
International journal of cancer. Journal international du cancer 2006;119(9):2119-26.
2006: Kathleen K Oros; Parviz Ghadirian; Christine M Maugard; Chantal Perret; Yosabeth Paredes; Anne-Marie Mes-Masson; William D Foulkes; Diane Provencher; Patricia N Tonin
Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descent.
Clinical genetics 2006;70(4):320-9.
2006: Philippe G Sauthier; Raymond Bélanger; Diane Provencher; Philippe Gauthier; Pierre Drouin
Clinical value of image-guided fine needle aspiration of retroperitoneal masses and lymph nodes in gynecologic oncology.
Gynecologic oncology 2006;103(1):75-80.
2006: Véronique Ouellet; Marie-Claude Guyot; Cecile Le Page; Abdelali Filali-Mouhim; Christian Lussier; Patricia N Tonin; Diane Provencher; Anne-Marie Mes-Masson
Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer.
International journal of cancer. Journal international du cancer 2006;119(3):599-607.
2006: Frederic Goffin; Marie-Hélène Mayrand; Philippe Gauthier; Abdulaziz Alobaid; Christian Lussier; Diane Provencher; Pierre Drouin; Eduardo L Franco; François Coutlée
High-risk human papillomavirus infection of the genital tract of women with a previous history or current high-grade vulvar intraepithelial neoplasia.
Journal of medical virology 2006;78(6):814-9.
2006: Patrick Petignat; Marjory Jolicoeur; Abdulaziz Alobaid; Pierre Drouin; Philippe Gauthier; Diane Provencher; David Donath; Thu Van Nguyen
Salvage treatment with high-dose-rate brachytherapy for isolated vaginal endometrial cancer recurrence.
Gynecologic oncology 2006;101(3):445-9.
2006: Cecile Le Page; Véronique Ouellet; Jason Madore; Thomas J Hudson; Patricia N Tonin; Diane Provencher; Anne-Marie Mes-Masson
From gene profiling to diagnostic markers: IL-18 and FGF-2 complement CA125 as serum-based markers in epithelial ovarian cancer.
International journal of cancer. Journal international du cancer 2006;118(7):1750-8.
2006: Cecile Le Page; Véronique Ouellet; Jason Madore; F Ren; Thomas J Hudson; Patricia N Tonin; Diane Provencher; Anne-Marie Mes-Masson
Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer.
British journal of cancer 2006;94(3):436-45.
2006: Kathleen K Oros; Guy Leblanc; Suzanna L Arcand; Zhen Shen; Chantal Perret; Anne-Marie Mes-Masson; William D Foulkes; Parviz Ghadirian; Diane Provencher; Patricia N Tonin
Haplotype analysis suggest common founders in carriers of the recurrent BRCA2 mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families.
BMC medical genetics 2006;7():23.
2005: Suzanna L Arcand; Diane Provencher; Anne-Marie Mes-Masson; Patricia N Tonin
OGG1 Cys326 variant, allelic imbalance of chromosome band 3p25.3 and TP53 mutations in ovarian cancer.
International journal of oncology 2005;27(5):1315-20.
2005: Patrick Petignat; Catherine Hankins; Sharon Walmsley; Deborah Money; Diane Provencher; Karina Pourreaux; Janet R Kornegay; Fabrice Rouah; François Coutlée
Self-sampling is associated with increased detection of human papillomavirus DNA in the genital tract of HIV-seropositive women.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(4):527-34.
2005: Véronique Ouellet; Diane Provencher; Christine M Maugard; Cecile Le Page; Fengge Ren; Christian Lussier; Jaroslav Novak; Bing Ge; Thomas J Hudson; Patricia N Tonin; Anne-Marie Mes-Masson
Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling.
Oncogene 2005;24(29):4672-87.
2005: Jean-Philippe Gagné; Pierre Gagné; Joanna M Hunter; Marie-Eve Bonicalzi; Jean-François Lemay; Isabelle Kelly; Cecile Le Page; Diane Provencher; Anne-Marie Mes-Masson; Arnaud Droit; David Bourgais; Guy G Poirier
Proteome profiling of human epithelial ovarian cancer cell line TOV-112D.
Molecular and cellular biochemistry 2005;275(1-2):25-55.
2005: Nadège Presneau; Ken Dewar; Vince Forgetta; Diane Provencher; Anne-Marie Mes-Masson; Patricia N Tonin
Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1-q25.2.
Molecular carcinogenesis 2005;43(3):141-54.
2005: Nadège Presneau; Zhen Shen; Diane Provencher; Anne-Marie Mes-Masson; Patricia N Tonin
Identification of novel variant, 1484delG in the 3'UTR of H3F3B, a member of the histone 3B replacement family, in ovarian tumors.
International journal of oncology 2005;26(6):1621-7.
2004: V Samouëlian; Christine M Maugard; M Jolicoeur; Richard Bertrand; Suzanna L Arcand; Patricia N Tonin; Diane Provencher; Anne-Marie Mes-Masson
Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFbeta-RII, KRAS2, TP53 and/or CDNK2A.
Cancer chemotherapy and pharmacology 2004;54(6):497-504.
2004: Kathleen K Oros; Parviz Ghadirian; Celia M T Greenwood; Chantal Perret; Zhen Shen; Yosabeth Paredes; Suzanna L Arcand; Anne-Marie Mes-Masson; Steven A Narod; William D Foulkes; Diane Provencher; Patricia N Tonin
Significant proportion of breast and/or ovarian cancer families of French Canadian descent harbor 1 of 5 BRCA1 and BRCA2 mutations.
International journal of cancer. Journal international du cancer 2004;112(3):411-9.
2004: Suzanna L Arcand; Anne-Marie Mes-Masson; Diane Provencher; Thomas J Hudson; Patricia N Tonin
Gene expression microarray analysis and genome databases facilitate the characterization of a chromosome 22 derived homogeneously staining region.
Molecular carcinogenesis 2004;41(1):17-38.
2004: Cecile Le Page; Diane Provencher; Christine M Maugard; Véronique Ouellet; Anne-Marie Mes-Masson
Signature of a silent killer: expression profiling in epithelial ovarian cancer.
Expert review of molecular diagnostics 2004;4(2):157-67.
2004: Brigitte Migneault; François Girard; Caroline Albert; Philippe Chouinard; Daniel Boudreault; Diane Provencher; Alexandre Todorov; Monique Ruel; Dominique C Girard
The effect of music on the neurohormonal stress response to surgery under general anesthesia.
Anesthesia and analgesia 2004;98(2):527-32, table of contents.
2003: Nadège Presneau; Anne-Marie Mes-Masson; Bing Ge; Diane Provencher; Thomas J Hudson; Patricia N Tonin
Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines.
Oncogene 2003;22(10):1568-79.
2003: Danh Tran-Thanh; Diane Provencher; Anita Koushik; Eliane Duarte; Allégria Kessous; Pierre Drouin; Cosette M Wheeler; Josée Dubuc-Lissoir; Philippe Gauthier; Guy Allaire; René Vauclair; Joseph A Dipaolo; Patti Gravitt; Eduardo Franco; François Coutlée
Herpes simplex virus type II is not a cofactor to human papillomavirus in cancer of the uterine cervix.
American journal of obstetrics and gynecology 2003;188(1):129-34.
2002: Danh Tran-Thanh; Anita Koushik; Diane Provencher; Pierre Drouin; Josée Dubuc-Lissoir; Philippe Gauthier; Guy Allaire; Janet R Kornegay; Eduardo Franco; François Coutlée
Detection of human herpes virus type 6 DNA in precancerous lesions of the uterine cervix.
Journal of medical virology 2002;68(4):606-10.
2002: Emily N Manderson; Nadège Presneau; Diane Provencher; Anne-Marie Mes-Masson; Patricia N Tonin
Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
Molecular carcinogenesis 2002;34(2):78-90.
2002: Emily N Manderson; Anne-Marie Mes-Masson; Jaroslav Novak; Peter D Lee; Diane Provencher; Thomas J Hudson; Patricia N Tonin
Expression profiles of 290 ESTs mapped to chromosome 3 in human epithelial ovarian cancer cell lines using DNA expression oligonucleotide microarrays.
Genome research 2002;12(1):112-21.
2001: Patricia N Tonin; Thomas J Hudson; F Rodier; Michela Bossolasco; Peter D Lee; J Novak; Emily N Manderson; Diane Provencher; Anne-Marie Mes-Masson
Microarray analysis of gene expression mirrors the biology of an ovarian cancer model.
Oncogene 2001;20(45):6617-26.
2001: A P Manning; D Abelovich; Parviz Ghadirian; J A Lambert; Danielle Frappier; Diane Provencher; André Robidoux; T Peretz; Steven A Narod; Anne-Marie Mes-Masson; William D Foulkes; T Wang; Kenneth Morgan; T Mary Fujiwara; Patricia N Tonin
Haplotype analysis of BRCA2 8765delAG mutation carriers in French Canadian and Yemenite Jewish hereditary breast cancer families.
Human heredity 2001;52(2):116-20.
2000: J Wang; Anne-Marie Mes-Masson; P N Tonin; Diane Provencher; P Eydoux
Trisomy of chromosome 10 in two cases of ovarian carcinoma.
Cancer genetics and cytogenetics 2000;118(1):65-8.
2000: F Dion; Anne-Marie Mes-Masson; RJ Seymour; Diane Provencher; PN Tonin
Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers.
Oncogene 2000;19(11):1466-72.
2000: Emily N Manderson; Anne-Marie Mes-Masson; Diane Provencher; Patricia N Tonin
Mutations in a 10-bp polyadenine repeat of transforming growth factor beta-receptor type II gene is an infrequent event in human epithelial ovarian cancer.
Clinical genetics 2000;57(2):151-3.
1999: Patricia N Tonin; Anne-Marie Mes-Masson; Steven A Narod; Parviz Ghadirian; Diane Provencher
Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history.
Clinical genetics 1999;55(5):318-24.
1999: A P Manning; Anne-Marie Mes-Masson; RJ Seymour; M Tetrault; Diane Provencher; PN Tonin
Expression of FHIT in primary cultures of human epithelial ovarian tumors and malignant ovarian ascites.
Molecular carcinogenesis 1999;24(3):218-25.
1998: H Lounis; Anne-Marie Mes-Masson; F Dion; W E Bradley; RJ Seymour; Diane Provencher; PN Tonin
Mapping of chromosome 3p deletions in human epithelial ovarian tumors.
Oncogene 1998;17(18):2359-65.
1998: Patricia N Tonin; Anne-Marie Mes-Masson; P A Futreal; Kenneth Morgan; M Mahon; William D Foulkes; David E C Cole; Diane Provencher; Parviz Ghadirian; Steven A Narod
Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.
American journal of human genetics 1998;63(5):1341-51.
1998: Steven A Narod; Harvey A Risch; Roxana Moslehi; A Dørum; Susan L Neuhausen; Håkan Olsson; Diane Provencher; P Radice; G Evans; S Bishop; Jean-Sebastien Brunet; bruce ponder
Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group.
The New England journal of medicine 1998;339(7):424-8.
1998: B Godard; William D Foulkes; Diane Provencher; Jean-Sebastien Brunet; P N Tonin; Anne-Marie Mes-Masson; Steven A Narod; Parviz Ghadirian
Risk factors for familial and sporadic ovarian cancer among French Canadians: a case-control study.
American journal of obstetrics and gynecology 1998;179(2):403-10.
1997: François Coutlée; Marie-Hélène Mayrand; Diane Provencher; Eduardo Franco
The future of HPV testing in clinical laboratories and applied virology research.
Clinical and diagnostic virology 1997;8(2):123-41.
1997: Diane Provencher; H Lounis; Dominique Fink; Pierre Drouin; Anne-Marie Mes-Masson
Discordance in p53 mutations when comparing ascites and solid tumors from patients with serous ovarian cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1997;18(3):167-74.
1995: François Coutlée; Diane Provencher; Hélène Voyer
Detection of human papillomavirus DNA in cervical lavage specimens by a nonisotopic consensus PCR assay.
Journal of clinical microbiology 1995;33(8):1973-8.
1995: A M Trottier; Diane Provencher; Anne-Marie Mes-Masson; R Vauclair; François Coutlée
Absence of human papillomavirus sequences in ovarian pathologies.
Journal of clinical microbiology 1995;33(4):1011-3.
1994: H Lounis; Diane Provencher; C Godbout; Dominique Fink; M J Milot; Anne-Marie Mes-Masson
Primary cultures of normal and tumoral human ovarian epithelium: a powerful tool for basic molecular studies.
Experimental cell research 1994;215(2):303-9.